Product: Nodify XL2,Nodify CDT
-
Real World Impact of a Blood Based Integrated Classifier on the Management of Benign Solid, Part Solid and Ground Glass Pulmonary Nodules
-
Comparison of a high specificity blood-based biomarker with FDG-PET for identifying malignant pulmonary nodules
-
Old Habits Die Hard: Managing Lung Nodules With Size Alone Is Not Sufficient
-
Use of Two Blood-Based Biomarker Tests in Series to Reclassify Risk of Indeterminate Pulmonary Nodules